FOLH1 and cancer: Apart from FDG and PSMA, several other tracers are currently being used and investigated in PET imaging, most prominently FAPI, which uses the tumor expression of fibroblast-activating protein (FAP) to diagnose and stage patients with cancers of the stomach or pancreas, and cholangiocarcinoma210.